Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation

Trial N/A Terminated Nov. 30, 2016

Haptoglobin and Iron in Parkinson's Disease

Trial N/A Completed Nov. 28, 2016

Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol

Trial N/A Unknown Nov. 28, 2016

Effect of Body Suspension and Tilting Exercises in Parkinson's Disease

Trial N/A Completed Nov. 27, 2016

Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients

Trial N/A Completed Nov. 27, 2016

Exercise for Adults With Parkinson Disease

Trial N/A Unknown Nov. 21, 2016

Effects of Deep Brain Stimulation in Parkinson's Disease

Trial N/A Unknown Nov. 20, 2016

Strength Training and Different Subtypes of Parkinson´s Disease

Trial N/A Completed Nov. 16, 2016

Trial of Exenatide for Parkinson's Disease

Trial Phase 2 Completed Nov. 16, 2016

Concurrent DBS Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation Device

Trial N/A Withdrawn Nov. 16, 2016

Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease

Trial N/A Completed Nov. 14, 2016

Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control

Trial N/A Completed Nov. 9, 2016

tDCS for Treatment of Depression in Parkinson's Disease

Trial N/A Unknown Nov. 9, 2016

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Trial Phase 2 Unknown Nov. 2, 2016

Exercise Intervention and Dexterity in Parkinson

Trial N/A Completed Nov. 1, 2016

Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.

Trial Phase 1 Completed Oct. 30, 2016

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

Trial Phase 1 Completed Oct. 30, 2016

Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

Trial N/A Terminated Oct. 30, 2016

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Trial Phase 2 Completed Oct. 27, 2016

A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

Trial Phase 1 Completed Oct. 25, 2016